HeartCore Reveals Launch Date for HeartCore CMS Version 13
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 25 2025
0mins
Should l Buy HTCR?
Source: Newsfilter
Launch of HeartCore CMS Version 13: HeartCore Enterprises is set to release HeartCore CMS Version 13 on September 30, 2025, featuring a redesigned user interface and advanced AI-driven marketing tools aimed at enhancing usability and digital marketing performance.
Key Features and SaaS Transition: The new version includes generative AI for SEO, AI-powered recommendations, and a streamlined management interface, while the company plans to promote migration to a Software-as-a-Service (SaaS) model, targeting a 50% transition of existing customers to increase maintenance fees by 1.5 times.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy HTCR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on HTCR
About HTCR
HeartCore Enterprises Inc is a Japan-based company mainly engaged in the development of software business. The Company provides software through two business units. The CX division business unit includes a customer experience management business (the CXM Platform). The CXM Platform includes marketing, sales, service and content management systems, as well as other tools and integrations, that enable companies to attract and engage customers throughout the customer experience. The Company also provides education, services and support to help customers be successful with CXM Platform. The DX division business unit is a digital transformation business which provides customers with robotics process automation, process mining and task mining to accelerate the digital transformation of enterprises.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Disappointing Earnings: HeartCore's released earnings report indicates a FY GAAP EPS of -$0.17, missing expectations by $0.14, which reflects a significant decline in profitability and may negatively impact investor confidence.
- Revenue Decline: The company reported FY revenue of $9 million, representing a 60.4% year-over-year decline, indicating weak market demand that could lead to future liquidity issues.
- Cautious Outlook: HeartCore expects FY revenue to be between $8.5 million and $9.5 million, reflecting uncertainty about future market conditions that may affect its strategic planning and investment decisions.
- Market Reaction Anticipation: Given the disappointing earnings performance, investors may react negatively to HeartCore's stock price, further exacerbating concerns about its long-term growth potential.
See More
- Reverse Stock Split Approval: HeartCore Enterprises' board has approved a 1-for-20 reverse stock split effective April 2, 2026, aimed at increasing the share price to meet Nasdaq's $1.00 minimum bid requirement for continued listing.
- Trading Changes: Following the reverse split, the company's common stock will trade under a new CUSIP number 42240Q 203 on Nasdaq starting April 6, 2026, marking a significant step towards compliance with listing standards.
- Market Reaction: Following the announcement, HTCR's stock price fell 22.87% in premarket trading to $0.173, indicating market caution regarding the split and potential impacts on investor confidence.
- Financial Outlook: HeartCore expects FY revenue between $8.5 million and $9.5 million, and despite facing stock price pressures, the company is striving for stable revenue growth.
See More
- Share Repurchase Program: HeartCore Enterprises announced a plan to repurchase up to $2 million of its common stock, aiming to enhance earnings per share by reducing the outstanding share count, thereby boosting investor confidence and stabilizing the stock price.
- Stock Price Reaction: Following the announcement, HTCR's stock price rose 7.56% in premarket trading to $0.283, indicating a positive market response to the repurchase plan, which may attract more investor interest.
- Financial Outlook: HeartCore expects FY revenue to be between $8.5 million and $9.5 million, suggesting that the company maintains a stable revenue base in the current market environment, potentially laying the groundwork for future growth.
- Market Signal: By implementing the share repurchase, HeartCore signals confidence in its own value, which may also attract institutional investors' attention, further enhancing the company's image in the capital markets.
See More
- Share Repurchase Program: HeartCore's Board has authorized a share repurchase program allowing for the buyback of up to $2 million in stock, reflecting management's view on the company's current valuation and long-term capital allocation priorities aimed at enhancing shareholder value.
- Asset vs. Market Capitalization: As of February 24, 2026, preliminary estimates indicate that HeartCore's total net assets exceed its market capitalization, an important factor in assessing the company's overall value and indicating strong financial health.
- Flexible Capital Allocation: The repurchase program will be executed through open market transactions and privately negotiated deals, with the timing and amount depending on market conditions and capital availability, showcasing the company's flexibility in capital allocation.
- Strategic Restructuring and Profit Outlook: This repurchase initiative follows the company's recent business restructuring and improved profitability outlook, demonstrating HeartCore's commitment to enhancing shareholder returns while focusing on financial consulting and IPO services.
See More
- Revenue Outlook: HeartCore Enterprises anticipates FY 2025 revenue between $8.5M and $9.5M, indicating potential growth despite challenges from revenue decline.
- Strategic Divestiture Impact: The completion of the divestiture of wholly-owned subsidiary HeartCore Japan on October 31, 2025, will exclude approximately $7M to $8M from consolidated revenue, aimed at optimizing resource allocation.
- Profitability Improvement: Despite the revenue decline, HeartCore expects net income for FY 2025 to be between $3M and $4M, a significant turnaround from a net loss of $5.2M in the previous year, showcasing improved profitability.
- Asset Disposal Gains: The sale of HeartCore Japan resulted in a gain of approximately $7M, alleviating revenue decline pressures and providing financial resources for future investments and growth.
See More








